{"lastClose": 7.829999923706055, "len": 568, "date": "2023-03-13", "alpha_1": 1.2417291965829103, "beta_1": 1.1683210329809193, "drawup_1": 2.551601332904123, "sharpe_1": 0.9208527819232387, "natr_1": 5.810631144047919, "sup_1": -0.0417198921686246, "res_1": 0.5193699314483141, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 46.029412713430176, "adx_1": 25.65475027494973, "drawdown_1": -0.5017730479964511, "stratHoldSharpe_1": 0.9383138001443312, "stratHoldAlpha_1": 251.63116944349022, "stratHoldDrawdown_1": -0.4565334247383772, "alpha_3mo": 0.23861203877348114, "beta_3mo": 0.9140255870391314, "drawup_3mo": 0.5144156769582451, "sharpe_3mo": 1.0525060602119192, "natr_3mo": 5.810631144047919, "sup_3mo": -0.056832696941461945, "res_3mo": 0.044061316915032116, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 37.5839024974094, "adx_3mo": 49.76647637072023, "drawdown_3mo": -0.23947890774280378, "stratHoldSharpe_3mo": 0.8053637695740443, "stratHoldAlpha_3mo": 251.5145545667918, "stratHoldDrawdown_3mo": -0.22166112393402704, "Market Cap": 5938486151, "Country": "United Kingdom", "Sector": "Health Care", "Name": "Roivant Sciences Ltd.", "Industry": "Biotechnology: Pharmaceutical Preparations", "alpha%_1": 0.999986996122474, "beta%_1": 0.6469657763007678, "drawup%_1": 0.999999988690059, "sharpe%_1": 0.7224220758037825, "natr%_1": 0.7348798817623857, "drawdown%_1": 0.2641442054999986, "stratHoldSharpe%_1": 0.8842005469464148, "stratHoldAlpha%_1": 0.9901365217345434, "stratHoldDrawdown%_1": 0.26995596351784834, "alpha%_3mo": 0.4065840936775933, "beta%_3mo": 0.44461613738708883, "drawup%_3mo": 0.9414746060670361, "sharpe%_3mo": 0.6220594752610923, "natr%_3mo": 0.7291572821361381, "drawdown%_3mo": 0.25082064700189577, "stratHoldSharpe%_3mo": 0.6948106715789568, "stratHoldAlpha%_3mo": 0.8421926118382488, "stratHoldDrawdown%_3mo": 0.23972072180635262}